What Do I Need to Sell Medical Devices in France?

To sell medical devices in France, you must comply with EU Medical Device Regulation (MDR) requirements, obtain CE marking, register with ANSM (the French national competent authority), and designate an In-Country Representative if you are a non-EU manufacturer. France follows the harmonized European framework while maintaining specific national requirements for market surveillance and post-market obligations.

What Are the Basic Regulatory Requirements for Selling Medical Devices in France?

France requires compliance with the EU Medical Device Regulation (MDR 2017/745), CE marking certification, ANSM notification, and appropriate regulatory representation for non-EU manufacturers. These requirements form the foundation of medical device market access in France.

The French medical device regulatory framework operates under ANSM (Agence nationale de sécurité du médicament et des produits de santé) oversight, which serves as the national competent authority. ANSM ensures that all medical devices entering the French market meet the safety and performance standards established by European regulations.

The core regulatory requirements include:

• EU MDR Compliance – All devices must conform to the Medical Device Regulation (MDR 2017/745), which establishes safety and performance requirements across all EU member states
• CE Marking Certification – This marking demonstrates conformity with applicable EU regulations through conformity assessment procedures conducted by notified bodies for higher-risk devices
• ANSM Registration – National notification with France’s competent authority ensures proper market surveillance and regulatory oversight
• In-Country Representative – Non-EU manufacturers must designate a local representative to handle regulatory communications and compliance obligations
• Quality Management Systems – ISO 13485 compliance ensures consistent device quality and regulatory adherence throughout the product lifecycle

These interconnected requirements create a comprehensive regulatory framework that prioritizes patient safety while enabling market access for compliant medical devices. Understanding each component’s specific obligations and interdependencies is essential for successful market entry, as failure to meet any single requirement can prevent or delay commercialization in France.

How Do You Navigate the ANSM Approval Process for Medical Devices?

ANSM-related requirements involve device classification, conformity assessment through notified bodies, clinical evidence generation, and ongoing post-market surveillance obligations. Timelines vary from weeks for Class I devices to several months for higher-risk classifications.

The ANSM approval process follows a structured pathway that varies based on device risk classification:

• Device Classification – Accurate classification according to MDR Annex VIII rules determines the conformity assessment pathway, with Class I devices following self-certification while higher classes require notified body involvement
• Clinical Evidence Requirements – Low-risk devices may rely on literature reviews and predicate comparisons, while implantable and life-supporting devices typically require clinical investigations
• EUDAMED Database Registration – Manufacturers must register devices, representatives, and importers for identification and traceability before market placement
• Conformity Assessment – Third-party evaluation by notified bodies for Class IIa, IIb, and III devices ensures compliance with safety and performance requirements
• Post-Market Surveillance Planning – Ongoing monitoring systems must be established for vigilance reporting, safety updates, and corrective actions

Timeline expectations range from 2–4 weeks for Class I devices to 6–12 months for Class III devices, depending on documentation completeness and clinical data requirements. The process requires careful coordination between classification accuracy, clinical evidence adequacy, and regulatory documentation quality to ensure efficient approval and sustained market access.

What Documentation and Testing Do You Need Before Entering the French Market?

French market entry requires technical documentation, clinical evaluation reports, ISO 13485 quality management certification, French labeling compliance, and conformity assessment certificates. This comprehensive documentation package demonstrates device safety and regulatory compliance.

The essential documentation requirements include:

• Technical Documentation – Comprehensive device descriptions, intended use statements, risk management files, design controls, and manufacturing information demonstrating MDR compliance
• Clinical Evaluation Reports – Evidence synthesis following MDCG guidance, including literature reviews, clinical investigation data, and post-market follow-up plans proportionate to device risk
• Quality Management Certification – ISO 13485 certification covering design controls, risk management, corrective actions, and manufacturing compliance verified through notified body audits
• French Labeling Compliance – Device labels and instructions in French, including CE marking, UDI codes, and clear manufacturer/representative identification
• Conformity Assessment Certificates – Declarations and certificates authorizing market placement, maintained throughout the device’s commercial life and updated for significant changes

This documentation framework ensures comprehensive regulatory compliance while demonstrating device safety and performance to French authorities. The interconnected nature of these requirements means that deficiencies in any area can delay market entry, making thorough preparation and expert review essential for efficient commercialization in France.

How Do You Maintain Compliance After Launching Your Medical Device in France?

Post-launch compliance requires EUDAMED database maintenance, adverse event reporting to ANSM, periodic safety update submissions, distributor oversight, and continuous regulatory monitoring. These ongoing obligations ensure sustained market access and patient safety.

Maintaining compliance involves several critical ongoing activities:

• EUDAMED Database Updates – Regular maintenance of device information, technical specifications, contact changes, and commercial status within specified timeframes to avoid violations
• Vigilance Reporting – Prompt notification of serious incidents and field safety corrective actions to ANSM, including investigation, root cause analysis, and corrective measure implementation
• Periodic Safety Updates – Regular synthesis of post-market surveillance data and clinical experience to evaluate benefit-risk profiles and identify emerging safety concerns
• Supply Chain Management – Clear distributor agreements defining regulatory responsibilities, adverse event reporting roles, and corrective action implementation throughout the distribution network
• Regulatory Intelligence – Continuous monitoring of regulatory changes, guidance updates, and enforcement activities to adapt compliance strategies to evolving requirements

These post-market obligations form a continuous cycle of monitoring, reporting, and improvement that extends throughout the device’s commercial life. Success requires proactive compliance management, robust quality systems, and ongoing regulatory expertise to navigate changing requirements while maintaining market access and ensuring patient safety in the French healthcare system.

How MedEnvoy Global Helps with French Medical Device Market Entry

Successfully entering and maintaining compliance in the French medical device market requires comprehensive regulatory expertise and ongoing commitment to quality and safety. MedEnvoy Global provides specialized solutions to streamline your market access and ensure sustained compliance throughout your commercial journey. Our services include:

• In-Country Representation – Complete regulatory representation services for non-EU manufacturers, including ANSM communications and compliance oversight
• Regulatory Consulting – Expert guidance on MDR compliance, device classification, clinical evidence requirements, and documentation preparation
• Post-Market Surveillance – Comprehensive vigilance reporting, EUDAMED maintenance, and ongoing compliance monitoring
• Strategic Market Entry Planning – Customized roadmaps for efficient French market access based on your device type and business objectives

Partner with MedEnvoy Global to navigate French regulatory requirements efficiently while you focus on innovation and growth. Contact our regulatory experts today to discuss your specific market entry needs and develop a tailored compliance strategy for the French medical device market.

Related Articles

• Do I Need a Mexican Importer for Medical Devices?
• When Should I Start the Mexico Registration Process?
• What’s the Cost of Medical Device Approval in Europe?
• What Are the Hidden Costs of Selling in Europe?
• What Are German-Specific Requirements for Medical Devices?